Non-Opioid Analgesics (NSAIDs, Acetaminophen, Others)

Non-opioid analgesics relieve pain without acting primarily at opioid receptors. The two most widely used classes are the nonsteroidal anti-inflammatory drugs (NSAIDs), which inhibit cyclooxygenase and prostaglandin synthesis, and acetaminophen (paracetamol); together with adjuvant agents they form the basis of much pain treatment and of opioid-sparing strategies.

Definition

Non-opioid analgesics are pain-relieving drugs whose primary mechanism does not involve opioid receptor activation; the major examples are nonsteroidal anti-inflammatory drugs (NSAIDs), which inhibit prostaglandin synthesis, and acetaminophen.

Scope

The topic covers the principal non-opioid analgesic classes — NSAIDs and acetaminophen, with reference to adjuvant analgesics — and their mechanisms, particularly cyclooxygenase inhibition. It treats them as a pharmacological class and provides no dosing or treatment instructions.

Core questions

• How do NSAIDs relieve pain and inflammation?
• How does acetaminophen differ mechanistically from NSAIDs?
• What roles do non-opioid analgesics play relative to opioids?
• Why are non-opioid agents central to opioid-sparing strategies?

Key concepts

• Nonsteroidal anti-inflammatory drugs (NSAIDs)
• Cyclooxygenase (COX-1, COX-2) inhibition
• Prostaglandin synthesis
• Acetaminophen (paracetamol)
• Anti-inflammatory vs analgesic effects
• Opioid-sparing effect
• Adjuvant analgesics

Mechanisms

NSAIDs relieve pain and inflammation by inhibiting cyclooxygenase, the enzyme that converts arachidonic acid to prostaglandins, which sensitize peripheral nociceptors and contribute to inflammation; this mechanism was established by Vane's (1971) demonstration that aspirin-like drugs inhibit prostaglandin synthesis. Acetaminophen has analgesic and antipyretic effects with little peripheral anti-inflammatory action, and its precise mechanism is less fully defined than that of the NSAIDs (Brunton et al., 2018). Because they act through pathways distinct from opioid receptors, non-opioid analgesics can complement opioids; meta-analytic evidence shows that adding an NSAID to opioid analgesia reduces opioid consumption and certain side effects after surgery (Marret et al., 2005).

Clinical relevance

Non-opioid analgesics are foundational to pain treatment and to strategies that reduce opioid exposure. This entry describes their mechanisms and pharmacological role for reference and education; it does not provide dosing, safety thresholds, or selection guidance, which depend on current clinical resources.

History

Salicylates have been used for pain and fever since antiquity, and aspirin was synthesized in the late nineteenth century, but the mechanism of this drug class remained obscure until Vane (1971) showed that aspirin-like drugs inhibit prostaglandin synthesis — work later recognized with a Nobel Prize. The subsequent distinction between cyclooxygenase isoforms refined understanding of NSAID action, while acetaminophen's mechanism has remained comparatively elusive (Brunton et al., 2018).

Key figures

• John Vane

Seminal works

• vane-1971
• marret-2005

Frequently asked questions

How do NSAIDs differ from opioids?

NSAIDs relieve pain by inhibiting cyclooxygenase and reducing prostaglandin synthesis at sites of injury and inflammation, whereas opioids act centrally on opioid receptors; the different mechanisms mean they have different effect and side-effect profiles and can be used together.

Why are non-opioid analgesics important for opioid-sparing care?

Because they relieve pain through non-opioid mechanisms, agents such as NSAIDs can be combined with opioids to achieve adequate analgesia at lower opioid doses, which meta-analytic evidence links to reduced opioid use and certain side effects after surgery.